A novel marker relationship between carotid intima media thickness and disease activity score-28 in patients with rheumatoid arthritis: Human endothelial cell-specific molecule-1.
Human endothelial cell-specific molecule-1 (Endocan), is a marker of vascular endothelial dysfunction that may be used in the evaluation of inflammatory-associated atherosclerotic lesions. Endocan may be a marker for the evaluation of atherosclerosis and disease activity in rheumatoid artritis (RA) patients. We included 39 RA patients who were assessed according to the American College of Rheumatology/European League Against Rheumatology 2010 diagnostic criteria and for the control group 30 age- and gender-matching healthy subjects recruited. Endocan values were 14.11 ± 3.27 for RA patients and 12.10 ± 2.92 for the control group. Endocan values of the patients were found to be statistically significantly higher when compared to the control group (p = 0.009). In the correlation analysis, Endocan showed a significantly positive correlation with disease activity score-28 (r = 0.386, p = 0.029) and carotid intima-media thickness (cIMT) (r = 0.419, p = 0.008). Linear regression analysis revealed that there was an independent relationship between Endocan and cIMT (p = 0.029). Endocan can be a marker for early atherosclerosis and disease activity in RA patients.